- Home
- VOC vs ATNM Comparison
VOC vs ATNM Comparison
Compare VOC & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- ATNM
- Stock Information
- Founded
- VOC 2010
- ATNM 2000
- Country
- VOC United States
- ATNM United States
- Employees
- VOC N/A
- ATNM N/A
- Industry
- VOC Oil & Gas Production
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- ATNM Health Care
- Exchange
- VOC Nasdaq
- ATNM Nasdaq
- Market Cap
- VOC 51.3M
- ATNM 50.2M
- IPO Year
- VOC 2011
- ATNM N/A
- Fundamental
- Price
- VOC $3.05
- ATNM $1.58
- Analyst Decision
- VOC
- ATNM Strong Buy
- Analyst Count
- VOC 0
- ATNM 2
- Target Price
- VOC N/A
- ATNM $4.50
- AVG Volume (30 Days)
- VOC 58.1K
- ATNM 116.8K
- Earning Date
- VOC 01-01-0001
- ATNM 11-13-2025
- Dividend Yield
- VOC 20.63%
- ATNM N/A
- EPS Growth
- VOC N/A
- ATNM N/A
- EPS
- VOC 0.57
- ATNM N/A
- Revenue
- VOC $11,024,911.00
- ATNM N/A
- Revenue This Year
- VOC N/A
- ATNM N/A
- Revenue Next Year
- VOC N/A
- ATNM N/A
- P/E Ratio
- VOC $5.27
- ATNM N/A
- Revenue Growth
- VOC N/A
- ATNM N/A
- 52 Week Low
- VOC $2.44
- ATNM $1.03
- 52 Week High
- VOC $5.69
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- VOC 68.67
- ATNM 42.17
- Support Level
- VOC $2.89
- ATNM $1.56
- Resistance Level
- VOC $2.94
- ATNM $1.64
- Average True Range (ATR)
- VOC 0.07
- ATNM 0.06
- MACD
- VOC 0.02
- ATNM -0.01
- Stochastic Oscillator
- VOC 91.67
- ATNM 6.67
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.